Viferon gel instructions for use
- Viferon gel instructions for use
ATX L03AB01 Code
Pharmacotherapeutic group : antiviral immunomodulatory agent.
Dosage form : gel for outdoor use.
Release form : opaque homogeneous gel-like mass of white color with a grayish tint, aluminum tube, cardboard box.
Immunomodulatory, antiviral, antiproliferative.
Active substances :
- recombinant human α-2b interferon (36 IU).
Auxiliary components :
- alpha-tocopherol acetate;
- tetraborate sodium decahydrate;
- benzoic acid;
- human serum albumin, 10%;
- sodium chloride;
- sodium carmellose;
- citric acid monohydrate;
- 95% ethanol;
- purified water.
Viferon gel has antiviral, immunomodulatory and antiproliferative effects. Suppresses viral nucleic acid replication. Enhances the phagocytic activity of macrophages, increases the specific cytotoxicity to the cells of lymphocyte targets. Due to the antioxidants (citric and benzoic acids) and α-tocopherol acetate included in the preparation, the antiviral activity and the immunomodulatory effect of interferon increase, which contributes to the effectiveness of the body’s immune response to infectious agents.
Under the influence of the drug, the number of locally produced IgA antibodies increases, which prevent the pathogenic microorganisms and viruses from fixing and multiplying on the mucous membranes of the upper respiratory tract.
Thanks to the gel basis, a prolonged effect of the drug is provided.
Due to the fact that this drug is a drug for external use, methods for clarifying the pharmacokinetic processes in the blood, used at the present stage, are not sensitive enough.
Indications for use
- As a drug for complex therapy of influenza, ARVI, complicated by bacterial infections;
- Recurrent stenosing larengotraheobronchitis (in complex therapy);
- Recurrent herpes virus infection (acute and exacerbation of the chronic form) of the skin and mucous membranes, including those affecting the urogenital area;
- Herpetic cervicitis (in complex therapy);
- Prevention of influenza and ARVI;
- Prevention of recurrent stenoziruyuschego larengotraheobronchitis.
- Hypersensitivity or individual intolerance to the components of the drug.
In view of the very low absorption of the components of the drug, pregnancy and lactation is not a contraindication to the use of the drug.
Dosage and administration
In the treatment of diseases of the upper respiratory tract, the gel is applied to the previously dried surface of the nasal mucosa or tonsils 3-5 times a day, in an amount of 0.5 cm. A cotton swab or spatula is used to apply it. The duration of therapy is 5 days, according to medical indications, the therapeutic course can be extended.
In order to prevent influenza and ARVI, Viferon gel is recommended to be applied to the mucous membrane in the same quantity for 2-4 weeks, 2 times a day.
When recurrent stenosing laryngotracheobronchitis drug is used in combination with other drugs. It is recommended to apply it on mucous membranes 5-7 days 5 times a day, and then, for 3 weeks - 3 times a day.
In order to prevent this pathology, the gel is used for 3-4 weeks 2 times a day, therapeutic courses are repeated 2 times a year.
When treating a herpevirus infection, Viferon is recommended to start using when the first signs of the disease appear, or during the prodromal period. The gel, in the amount of 0.5 cm is applied to the affected area 3-5 times a day for 5-6 days. According to medical indications, the duration of the course increases to the disappearance of clinical symptoms.
In the treatment of herpetic cervicitis, the gel is applied to the cervix pre-cleaned of mucus, in an amount of 1 ml. The procedure should be carried out for 7 days, 2 times a day. According to medical indications, the duration of the course is increased to 14 days.
When using the drug may develop allergic skin reactions (itching, urticaria , skin flushing).
Viferon gel is perfectly combined with all antiviral, antibacterial, anti-inflammatory drugs, as well as chemotherapy drugs used in the treatment of diseases indicated in the indications.
Data overdose gel Viferon is not available.
Does not affect the ability to manage motor transport. During lactation is not recommended to be applied to the nipple and areola.
Refers to non-prescription drugs.
Store in a dry, protected from light, out of reach of children at a temperature of 2-8 C.
The shelf life of the drug is 1 year from the date of issue. After the expiration date indicated on the package, the drug is not allowed to use.
Viferon gel price
The average price in Moscow pharmacies is 150.00 rubles.
Viferon gel and taxes